Conclusion Both GLP-1 agonists and SGLT2 inhibitors represent significant advances in Type 2 diabetes care
We use non-GMO, organic, and wild-crafted ingredients whenever possible, and we follow GMP-aligned manufacturing standards to ensure every batch meets our high expectations
Ethics declarations Competing interests Cristian-Daniel Llach received financial support from the La Caixa Foundation, which provided salary support during the fellowship through its fellowship programs
Any claim for retatrutide being good for brain health is currently reasoning from a hypothesis, not from human data
They truly want to see you succeed, and it shows
Heart Health Protection When people who are overweight use GLP-1 medications, they tend to experience broad cardiovascular and metabolic health improvements, depending on the medication